{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T23:46:51Z","timestamp":1774396011615,"version":"3.50.1"},"reference-count":178,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001807","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de S\u00e3o Paulo","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Prostaglandins &amp; Other Lipid Mediators"],"published-print":{"date-parts":[[2021,4]]},"DOI":"10.1016\/j.prostaglandins.2020.106522","type":"journal-article","created":{"date-parts":[[2020,12,21]],"date-time":"2020-12-21T11:03:26Z","timestamp":1608548606000},"page":"106522","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"special_numbering":"C","title":["Platelet activating factor in the eye: Physiological roles, diseases and future perspectives"],"prefix":"10.1016","volume":"153","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1189-5837","authenticated-orcid":false,"given":"Barbara","family":"Dalmaso","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ildefonso Alves","family":"da Silva-Junior","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6747-2828","authenticated-orcid":false,"given":"Lucianne","family":"Fragel-Madeira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sonia","family":"Jancar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8540-9897","authenticated-orcid":false,"given":"Carolina Beltrame","family":"Del Debbio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"24","key":"10.1016\/j.prostaglandins.2020.106522_bib0005","doi-asserted-by":"crossref","first-page":"15043","DOI":"10.1074\/jbc.272.24.15043","article-title":"A thematic series on phospholipases","volume":"272","author":"Prescott","year":"1997","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.prostaglandins.2020.106522_bib0010","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1146\/annurev.biochem.69.1.419","article-title":"Platelet-activating factor and related lipid mediators","volume":"69","author":"Prescott","year":"2000","journal-title":"Annu. Rev. Biochem."},{"issue":"6","key":"10.1016\/j.prostaglandins.2020.106522_bib0015","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1084\/jem.136.6.1356","article-title":"Leukocyte-dependent histamine release from rabbit platelets. The role of IgE, basophils, and a platelet-activating factor","volume":"136","author":"Benveniste","year":"1972","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.prostaglandins.2020.106522_bib0020","first-page":"13","article-title":"Platelet activating factor (PAF). A possible direct mediator of anaphylaxis in the rabbit and a trigger for the vascular deposition of circulating immune complexes","volume":"12","author":"Henson","year":"1977","journal-title":"Monogr. Allergy"},{"issue":"24","key":"10.1016\/j.prostaglandins.2020.106522_bib0025","doi-asserted-by":"crossref","first-page":"4511","DOI":"10.1016\/0006-2952(86)90772-0","article-title":"Species difference in the specific receptors of platelet activating factor","volume":"35","author":"Hwang","year":"1986","journal-title":"Biochem. Pharmacol."},{"issue":"23","key":"10.1016\/j.prostaglandins.2020.106522_bib0030","doi-asserted-by":"crossref","DOI":"10.3390\/molecules24234414","article-title":"Forty years since the structural elucidation of platelet-activating factor (PAF): historical, current, and future research perspectives","volume":"24","author":"Lordan","year":"2019","journal-title":"Molecules"},{"issue":"2","key":"10.1016\/j.prostaglandins.2020.106522_bib0035","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/0005-2760(88)90304-9","article-title":"Production and effects of platelet-activating factor in the rat brain","volume":"963","author":"Kumar","year":"1988","journal-title":"Biochim. Biophys. Acta"},{"issue":"12","key":"10.1016\/j.prostaglandins.2020.106522_bib0040","first-page":"2672","article-title":"Localization of platelet-activating factor receptor messenger RNA in the rat eye","volume":"38","author":"Mori","year":"1997","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"issue":"1","key":"10.1016\/j.prostaglandins.2020.106522_bib0045","doi-asserted-by":"crossref","first-page":"45","DOI":"10.3109\/02713689409042397","article-title":"Differences in the acyl composition of the platelet-activating factor (PAF) precursor and other choline phosphoglycerides of the rabbit retinal rod outer segments and neural retina","volume":"13","author":"Bazan","year":"1994","journal-title":"Curr. Eye Res."},{"issue":"7","key":"10.1016\/j.prostaglandins.2020.106522_bib0050","doi-asserted-by":"crossref","first-page":"2973","DOI":"10.1096\/fj.201601183R","article-title":"Relief from neuropathic pain by blocking of the platelet-activating factor-pain loop","volume":"31","author":"Shindou","year":"2017","journal-title":"FASEB J."},{"issue":"5","key":"10.1016\/j.prostaglandins.2020.106522_bib0055","doi-asserted-by":"crossref","first-page":"3448","DOI":"10.1007\/s12035-015-9263-6","article-title":"Attenuated reactive gliosis and enhanced functional recovery following spinal cord injury in null mutant mice of platelet-activating factor receptor","volume":"53","author":"Wang","year":"2016","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.prostaglandins.2020.106522_bib0060","doi-asserted-by":"crossref","first-page":"30298","DOI":"10.1038\/srep30298","article-title":"Dysfunctional epileptic neuronal circuits and dysmorphic dendritic spines are mitigated by platelet-activating factor receptor antagonism","volume":"6","author":"Musto","year":"2016","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.prostaglandins.2020.106522_bib0065","doi-asserted-by":"crossref","first-page":"178","DOI":"10.3390\/biom5010178","article-title":"\u03b1-Synuclein-induced synapse damage in cultured neurons is mediated by cholesterol-sensitive activation of cytoplasmic phospholipase A2","volume":"5","author":"Bate","year":"2015","journal-title":"Biomolecules"},{"issue":"10","key":"10.1016\/j.prostaglandins.2020.106522_bib0070","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1517\/14728222.2012.712961","article-title":"Ocular actions of platelet-activating factor: clinical implications","volume":"16","author":"Nitoda","year":"2012","journal-title":"Expert Opin. Ther. Targets"},{"key":"10.1016\/j.prostaglandins.2020.106522_bib0075","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.prostaglandins.2016.01.001","article-title":"Association between platelet activating factor acetylhydrolase and diabetic retinopathy: does inflammation affect the retinal status?","volume":"122","author":"Moschos","year":"2016","journal-title":"Prostaglandins Other Lipid Mediat."},{"issue":"9","key":"10.1016\/j.prostaglandins.2020.106522_bib0080","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1517\/14728222.2014.930439","article-title":"Correlation of platelet activating factor and age-related macular degeneration","volume":"18","author":"Nitoda","year":"2014","journal-title":"Expert Opin. Ther. Targets"},{"issue":"6","key":"10.1016\/j.prostaglandins.2020.106522_bib0085","doi-asserted-by":"crossref","first-page":"e68173","DOI":"10.1371\/journal.pone.0068173","article-title":"A novel platelet-activating factor receptor antagonist inhibits choroidal neovascularization and subretinal fibrosis","volume":"8","author":"Zhang","year":"2013","journal-title":"PLoS One"},{"issue":"6","key":"10.1016\/j.prostaglandins.2020.106522_bib0090","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1080\/02713683.2018.1454476","article-title":"Platelet-activating factor (PAF) receptor antagonism modulates inflammatory signaling in experimental uveitis","volume":"43","author":"Elison","year":"2018","journal-title":"Curr. Eye Res."},{"issue":"5","key":"10.1016\/j.prostaglandins.2020.106522_bib0095","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1076\/ceyr.17.5.501.5194","article-title":"The role of platelet-activating factor in cell infiltration in endotoxin-induced uveitis in guinea pigs","volume":"17","author":"Tsuji","year":"1998","journal-title":"Curr. Eye Res."},{"issue":"8","key":"10.1016\/j.prostaglandins.2020.106522_bib0100","first-page":"2393","article-title":"Lipid mediators of tumor necrosis factor-alpha-induced uveitis","volume":"32","author":"Fleisher","year":"1991","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.prostaglandins.2020.106522_bib0105","first-page":"1639","article-title":"Identification of candidate genes for human retinal degeneration loci using differentially expressed genes from mouse photoreceptor dystrophy models","volume":"14","author":"Demos","year":"2008","journal-title":"Mol. Vis."},{"issue":"35","key":"10.1016\/j.prostaglandins.2020.106522_bib0110","doi-asserted-by":"crossref","first-page":"15523","DOI":"10.1073\/pnas.1002897107","article-title":"Loss of lysophosphatidylcholine acyltransferase 1 leads to photoreceptor degeneration in rd11 mice","volume":"107","author":"Friedman","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"5","key":"10.1016\/j.prostaglandins.2020.106522_bib0115","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1089\/jop.2006.22.347","article-title":"Pharmacokinetic analysis of platelet-activating factor in the tears of guinea pigs with allergic conjunctivitis","volume":"22","author":"Okumura","year":"2006","journal-title":"J. Ocul. Pharmacol. Ther."},{"issue":"4","key":"10.1016\/j.prostaglandins.2020.106522_bib0120","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1254\/jphs.FP0040265","article-title":"Apafant, a potent platelet-activating factor antagonist, blocks eosinophil activation and is effective in the chronic phase of experimental allergic conjunctivitis in guinea pigs","volume":"95","author":"Kato","year":"2004","journal-title":"J. Pharmacol. Sci."},{"issue":"4","key":"10.1016\/j.prostaglandins.2020.106522_bib0125","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1111\/j.1582-4934.2002.tb00462.x","article-title":"Significance of platelet-activating factor acetylhydrolase in patients with non-insulin-dependent (type 2) diabetes mellitus","volume":"6","author":"Serban","year":"2002","journal-title":"J. Cell. Mol. Med."},{"issue":"6","key":"10.1016\/j.prostaglandins.2020.106522_bib0130","doi-asserted-by":"crossref","first-page":"E1276","DOI":"10.1152\/ajpendo.00475.2009","article-title":"A regulatory role of LPCAT1 in the synthesis of inflammatory lipids, PAF and LPC, in the retina of diabetic mice","volume":"297","author":"Cheng","year":"2009","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"issue":"1","key":"10.1016\/j.prostaglandins.2020.106522_bib0135","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/S0014-2999(98)00664-5","article-title":"Effect of WEB 2086-BS, an antagonist of platelet-activating factor receptors, on retinal vascularity in diabetic rats","volume":"360","author":"de la Cruz","year":"1998","journal-title":"Eur. J. Pharmacol."},{"issue":"7","key":"10.1016\/j.prostaglandins.2020.106522_bib0140","doi-asserted-by":"crossref","first-page":"5563","DOI":"10.1007\/s12035-016-0062-5","article-title":"Current understanding of platelet-activating factor signaling in central nervous system diseases","volume":"54","author":"Liu","year":"2017","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.prostaglandins.2020.106522_bib0145","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/978-1-4899-0179-8_2","article-title":"Biosynthesis of platelet-activating factor and enzyme inhibitors","volume":"416","author":"Snyder","year":"1996","journal-title":"Adv. Exp. Med. Biol."},{"issue":"17","key":"10.1016\/j.prostaglandins.2020.106522_bib0150","doi-asserted-by":"crossref","first-page":"11097","DOI":"10.1074\/jbc.M708909200","article-title":"Identification of a novel noninflammatory biosynthetic pathway of platelet-activating factor","volume":"283","author":"Harayama","year":"2008","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.prostaglandins.2020.106522_bib0155","doi-asserted-by":"crossref","first-page":"10355","DOI":"10.1038\/s41598-020-67000-x","article-title":"Lysophosphatidylcholine acyltransferase 2 (LPCAT2) co-localises with TLR4 and regulates macrophage inflammatory gene expression in response to LPS","volume":"10","author":"Abate","year":"2020","journal-title":"Sci. Rep."},{"issue":"31","key":"10.1016\/j.prostaglandins.2020.106522_bib0160","doi-asserted-by":"crossref","first-page":"11724","DOI":"10.1073\/pnas.0604946103","article-title":"Identification and characterization of a lysophosphatidylcholine acyltransferase in alveolar type II cells","volume":"103","author":"Chen","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"29","key":"10.1016\/j.prostaglandins.2020.106522_bib0165","doi-asserted-by":"crossref","first-page":"20140","DOI":"10.1074\/jbc.M600225200","article-title":"Cloning and characterization of mouse lung-type acyl-CoA:lysophosphatidylcholine acyltransferase 1 (LPCAT1). Expression in alveolar type II cells and possible involvement in surfactant production","volume":"281","author":"Nakanishi","year":"2006","journal-title":"J. Biol. Chem."},{"issue":"Suppl","key":"10.1016\/j.prostaglandins.2020.106522_bib0170","doi-asserted-by":"crossref","first-page":"S46","DOI":"10.1194\/jlr.R800035-JLR200","article-title":"Recent progress on acyl CoA: lysophospholipid acyltransferase research","volume":"50","author":"Shindou","year":"2009","journal-title":"J. Lipid Res."},{"issue":"9","key":"10.1016\/j.prostaglandins.2020.106522_bib0175","doi-asserted-by":"crossref","first-page":"6532","DOI":"10.1074\/jbc.M609641200","article-title":"A single enzyme catalyzes both platelet-activating factor production and membrane biogenesis of inflammatory cells. Cloning and characterization of acetyl-CoA:LYSO-PAF acetyltransferase","volume":"282","author":"Shindou","year":"2007","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.prostaglandins.2020.106522_bib0180","doi-asserted-by":"crossref","first-page":"106478","DOI":"10.1016\/j.prostaglandins.2020.106478","article-title":"Effect of acyl and alkyl analogs of platelet-activating factor on inflammatory signaling","volume":"151","author":"Marathe","year":"2020","journal-title":"Prostaglandins Other Lipid Mediat."},{"issue":"1\u20132","key":"10.1016\/j.prostaglandins.2020.106522_bib0185","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/S0005-2760(97)00109-4","article-title":"CDP-choline:alkylacetylglycerol cholinephosphotransferase catalyzes the final step in the de novo synthesis of platelet-activating factor","volume":"1348","author":"Snyder","year":"1997","journal-title":"Biochim. Biophys. Acta"},{"issue":"3","key":"10.1016\/j.prostaglandins.2020.106522_bib0190","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/j.bbalip.2012.09.009","article-title":"Phosphatidylcholine and the CDP-choline cycle","volume":"1831","author":"Fagone","year":"2013","journal-title":"Biochim. Biophys. Acta"},{"issue":"2","key":"10.1016\/j.prostaglandins.2020.106522_bib0195","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/0005-2760(94)90122-8","article-title":"Platelet-aggregating effects of platelet-activating factor-like phospholipids formed by oxidation of phosphatidylcholines containing an sn-2-polyunsaturated fatty acyl group","volume":"1210","author":"Tanaka","year":"1994","journal-title":"Biochim. Biophys. Acta"},{"issue":"11","key":"10.1016\/j.prostaglandins.2020.106522_bib0200","doi-asserted-by":"crossref","first-page":"2365","DOI":"10.1194\/jlr.M700325-JLR200","article-title":"Intracellular PAF catabolism by PAF acetylhydrolase counteracts continual PAF synthesis","volume":"48","author":"Chen","year":"2007","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.prostaglandins.2020.106522_bib0205","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/bs.enz.2015.09.007","article-title":"Intracellular PAF-Acetylhydrolase type I","volume":"38","author":"Hattori","year":"2015","journal-title":"Enzymes"},{"key":"10.1016\/j.prostaglandins.2020.106522_bib0210","series-title":"Metabolism and Functions of Platelet-Activating Factor (PAF) in the Nervous Tissue, Handbook of Neurochemistry and Molecular Neurobiology: Neural Lipids","first-page":"311","author":"Goracci","year":"2009"},{"issue":"6","key":"10.1016\/j.prostaglandins.2020.106522_bib0215","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1016\/j.conb.2013.08.001","article-title":"LIS1 functions in normal development and disease","volume":"23","author":"Reiner","year":"2013","journal-title":"Curr. Opin. Neurobiol."},{"issue":"5","key":"10.1016\/j.prostaglandins.2020.106522_bib0220","first-page":"809","article-title":"Coupling PAF signaling to dynein regulation: structure of LIS1 in complex with PAF-acetylhydrolase","volume":"44","author":"Tarricone","year":"2004","journal-title":"Neuron"},{"issue":"11","key":"10.1016\/j.prostaglandins.2020.106522_bib0225","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1101\/gad.1417206","article-title":"The cellular roles of the lissencephaly gene LIS1, and what they tell us about brain development","volume":"20","author":"Vallee","year":"2006","journal-title":"Genes Dev."},{"issue":"1","key":"10.1016\/j.prostaglandins.2020.106522_bib0230","doi-asserted-by":"crossref","DOI":"10.1523\/ENEURO.0350-17.2018","article-title":"An essential postdevelopmental role for Lis1 in mice","volume":"5","author":"Hines","year":"2018","journal-title":"eNeuro"},{"issue":"49","key":"10.1016\/j.prostaglandins.2020.106522_bib0235","doi-asserted-by":"crossref","first-page":"15520","DOI":"10.1523\/JNEUROSCI.4630-09.2009","article-title":"Distinct dose-dependent cortical neuronal migration and neurite extension defects in Lis1 and Ndel1 mutant mice","volume":"29","author":"Youn","year":"2009","journal-title":"J. Neurosci."},{"key":"10.1016\/j.prostaglandins.2020.106522_bib0240","doi-asserted-by":"crossref","DOI":"10.3389\/fncel.2010.00019","article-title":"PAF-AH catalytic subunits modulate the wnt pathway in developing GABAergic neurons","volume":"4","author":"Livnat","year":"2010","journal-title":"Front. Cell. Neurosci."},{"issue":"6","key":"10.1016\/j.prostaglandins.2020.106522_bib0245","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1093\/oxfordjournals.jbchem.a003164","article-title":"Platelet-activating factor receptor","volume":"131","author":"Honda","year":"2002","journal-title":"J. Biochem."},{"issue":"1","key":"10.1016\/j.prostaglandins.2020.106522_bib0250","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S0163-7827(99)00016-8","article-title":"Platelet-activating factor (PAF) receptor and genetically engineered PAF receptor mutant mice","volume":"39","author":"Ishii","year":"2000","journal-title":"Prog. Lipid Res."},{"key":"10.1016\/j.prostaglandins.2020.106522_bib0255","first-page":"79","article-title":"Phosphatidylinositol 3-kinase: the oncoprotein","volume":"347","author":"Vogt","year":"2010","journal-title":"Curr. Top. Microbiol. Immunol."},{"issue":"1","key":"10.1016\/j.prostaglandins.2020.106522_bib0260","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1128\/MMBR.00031-10","article-title":"Activation and function of the MAPKs and their substrates, the MAPK-activated protein kinases","volume":"75","author":"Cargnello","year":"2011","journal-title":"Microbiol. Mol. Biol. Rev."},{"issue":"5","key":"10.1016\/j.prostaglandins.2020.106522_bib0265","doi-asserted-by":"crossref","first-page":"3242","DOI":"10.4049\/jimmunol.177.5.3242","article-title":"Activation and regulation of platelet-activating factor receptor: role of G(i) and G(q) in receptor-mediated chemotactic, cytotoxic, and cross-regulatory signals","volume":"177","author":"Brown","year":"2006","journal-title":"J. Immunol."},{"issue":"5 Suppl","key":"10.1016\/j.prostaglandins.2020.106522_bib0270","doi-asserted-by":"crossref","first-page":"S294","DOI":"10.1097\/00003246-200205001-00020","article-title":"The platelet-activating factor signaling system and its regulators in syndromes of inflammation and thrombosis","volume":"30","author":"Zimmerman","year":"2002","journal-title":"Crit. Care Med."},{"key":"10.1016\/j.prostaglandins.2020.106522_bib0275","doi-asserted-by":"crossref","first-page":"16017","DOI":"10.1038\/celldisc.2016.17","article-title":"Nuclear localization of platelet-activating factor receptor controls retinal neovascularization","volume":"2","author":"Bhosle","year":"2016","journal-title":"Cell Discov."},{"issue":"4","key":"10.1016\/j.prostaglandins.2020.106522_bib0280","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.1152\/physrev.2000.80.4.1669","article-title":"Role of platelet-activating factor in cardiovascular pathophysiology","volume":"80","author":"Montrucchio","year":"2000","journal-title":"Physiol. Rev."},{"issue":"4","key":"10.1016\/j.prostaglandins.2020.106522_bib0285","doi-asserted-by":"crossref","first-page":"390","DOI":"10.2174\/187152609788922555","article-title":"The implication of platelet activating factor in cancer growth and metastasis: potent beneficial role of PAF-inhibitors and antioxidants","volume":"9","author":"Tsoupras","year":"2009","journal-title":"Infect. Disord. Drug Targets"},{"issue":"1","key":"10.1016\/j.prostaglandins.2020.106522_bib0290","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1124\/mol.108.051003","article-title":"Opposing effects of platelet-activating factor and lyso-platelet-activating factor on neutrophil and platelet activation","volume":"75","author":"Welch","year":"2009","journal-title":"Mol. Pharmacol."},{"issue":"5\u20136","key":"10.1016\/j.prostaglandins.2020.106522_bib0295","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/S0301-0082(96)00047-0","article-title":"Platelet-activating factor in the CNS","volume":"50","author":"Maclennan","year":"1996","journal-title":"Prog. Neurobiol."},{"issue":"1\u20133","key":"10.1016\/j.prostaglandins.2020.106522_bib0300","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/0929-7855(96)00543-3","article-title":"Platelet-activating factor as a potential retrograde messenger","volume":"14","author":"Kato","year":"1996","journal-title":"J. Lipid Mediat. Cell Signal."},{"issue":"6459","key":"10.1016\/j.prostaglandins.2020.106522_bib0305","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1038\/367175a0","article-title":"Platelet-activating factor as a potential retrograde messenger in CA1 hippocampal long-term potentiation","volume":"367","author":"Kato","year":"1994","journal-title":"Nature"},{"key":"10.1016\/j.prostaglandins.2020.106522_bib0310","first-page":"505","article-title":"Platelet activating factor enhances synaptic vesicle exocytosis via PKC, elevated intracellular calcium, and modulation of synapsin 1 dynamics and phosphorylation","volume":"9","author":"Hammond","year":"2015","journal-title":"Front. Cell. Neurosci."},{"issue":"1","key":"10.1016\/j.prostaglandins.2020.106522_bib0315","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1152\/jn.2001.85.1.384","article-title":"Attenuated LTP in hippocampal dentate gyrus neurons of mice deficient in the PAF receptor","volume":"85","author":"Chen","year":"2001","journal-title":"J. Neurophysiol."},{"issue":"3","key":"10.1016\/j.prostaglandins.2020.106522_bib0320","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1006\/nlme.1998.3862","article-title":"Effects of posttraining intrahippocampal injections of platelet-activating factor and PAF antagonists on memory","volume":"70","author":"Teather","year":"1998","journal-title":"Neurobiol. Learn. Mem."},{"issue":"3","key":"10.1016\/j.prostaglandins.2020.106522_bib0325","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1046\/j.1471-4159.1997.69030889.x","article-title":"Phospholipase A2 and its role in brain tissue","volume":"69","author":"Farooqui","year":"1997","journal-title":"J. Neurochem."},{"issue":"3\u20134","key":"10.1016\/j.prostaglandins.2020.106522_bib0330","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1615\/CritRevImmunol.v17.i3-4.10","article-title":"Regulatory functions of phospholipase A2","volume":"17","author":"Murakami","year":"1997","journal-title":"Crit. Rev. Immunol."},{"issue":"3","key":"10.1016\/j.prostaglandins.2020.106522_bib0335","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1097\/00001756-200403010-00025","article-title":"The role of platelet activating factor in prion and amyloid-beta neurotoxicity","volume":"15","author":"Bate","year":"2004","journal-title":"Neuroreport"},{"issue":"1","key":"10.1016\/j.prostaglandins.2020.106522_bib0340","doi-asserted-by":"crossref","first-page":"e16058","DOI":"10.1371\/journal.pone.0016058","article-title":"Platelet activating factor blocks interkinetic nuclear migration in retinal progenitors through an arrest of the cell cycle at the S\/G2 transition","volume":"6","author":"Fragel-Madeira","year":"2011","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.prostaglandins.2020.106522_bib0345","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1007\/s12035-010-8129-1","article-title":"Role of platelet-activating factor in cell death signaling in the cornea: a review","volume":"42","author":"Esquenazi","year":"2010","journal-title":"Mol. Neurobiol."},{"issue":"3","key":"10.1016\/j.prostaglandins.2020.106522_bib0350","first-page":"790","article-title":"PAF binding to a single receptor in corneal epithelium plasma membrane","volume":"40","author":"Hurst","year":"1999","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"issue":"7","key":"10.1016\/j.prostaglandins.2020.106522_bib0355","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1089\/wound.2013.0473","article-title":"Epithelialization in wound healing: a comprehensive review","volume":"3","author":"Pastar","year":"2014","journal-title":"Adv. Wound Care (New Rochelle)"},{"issue":"7","key":"10.1016\/j.prostaglandins.2020.106522_bib0360","first-page":"1696","article-title":"Increased platelet-activating factor receptor gene expression by corneal epithelial wound healing","volume":"41","author":"Ma","year":"2000","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"issue":"4","key":"10.1016\/j.prostaglandins.2020.106522_bib0365","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/0014-4835(91)90046-H","article-title":"Platelet-activating factor (PAF) accumulation correlates with injury in the cornea","volume":"52","author":"Bazan","year":"1991","journal-title":"Exp. Eye Res."},{"issue":"18","key":"10.1016\/j.prostaglandins.2020.106522_bib0370","doi-asserted-by":"crossref","first-page":"8678","DOI":"10.1073\/pnas.90.18.8678","article-title":"Platelet-activating factor induces collagenase expression in corneal epithelial cells","volume":"90","author":"Bazan","year":"1993","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"2","key":"10.1016\/j.prostaglandins.2020.106522_bib0375","first-page":"345","article-title":"Platelet-activating factor induces the expression of metalloproteinases-1 and -9, but not -2 or -3, in the corneal epithelium","volume":"36","author":"Tao","year":"1995","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"issue":"10","key":"10.1016\/j.prostaglandins.2020.106522_bib0380","first-page":"2037","article-title":"Platelet-activating factor enhances urokinase-type plasminogen activator gene expression in corneal epithelium","volume":"37","author":"Tao","year":"1996","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"issue":"2","key":"10.1016\/j.prostaglandins.2020.106522_bib0385","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1167\/iovs.04-0852","article-title":"PAF-induced furin and MT1-MMP expression is independent of MMP-2 activation in corneal myofibroblasts","volume":"46","author":"Ottino","year":"2005","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"issue":"5","key":"10.1016\/j.prostaglandins.2020.106522_bib0390","doi-asserted-by":"crossref","first-page":"1931","DOI":"10.1167\/iovs.06-1008","article-title":"Platelet-activating factor overturns the transcriptional repressor disposition of Sp1 in the expression of MMP-9 in human corneal epithelial cells","volume":"48","author":"Taheri","year":"2007","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"issue":"4","key":"10.1016\/j.prostaglandins.2020.106522_bib0395","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1076\/ceyr.16.4.372.10699","article-title":"A mitogen-activated protein kinase (MAP-kinase) cascade is stimulated by platelet activating factor (PAF) in corneal epithelium","volume":"16","author":"Bazan","year":"1997","journal-title":"Curr. Eye Res."},{"issue":"Suppl","key":"10.1016\/j.prostaglandins.2020.106522_bib0400","doi-asserted-by":"crossref","first-page":"S12","DOI":"10.1007\/PL00007449","article-title":"Proteolytic mechanisms in corneal ulceration and repair","volume":"290","author":"Fini","year":"1998","journal-title":"Arch. Dermatol. Res."},{"issue":"3","key":"10.1016\/j.prostaglandins.2020.106522_bib0405","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1089\/jop.1997.13.277","article-title":"PAF antagonists as possible inhibitors of corneal epithelial defects and ulceration","volume":"13","author":"Bazan","year":"1997","journal-title":"J. Ocul. Pharmacol. Ther."},{"issue":"2","key":"10.1016\/j.prostaglandins.2020.106522_bib0410","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1076\/ceyr.23.2.77.5471","article-title":"Corneal stimulation of MMP-1, -9 and uPA by platelet-activating factor is mediated by cyclooxygenase-2 metabolites","volume":"23","author":"Ottino","year":"2001","journal-title":"Curr. Eye Res."},{"issue":"5","key":"10.1016\/j.prostaglandins.2020.106522_bib0415","first-page":"1422","article-title":"Delay of corneal epithelial wound healing and induction of keratocyte apoptosis by platelet-activating factor","volume":"43","author":"Chandrasekher","year":"2002","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"issue":"1","key":"10.1016\/j.prostaglandins.2020.106522_bib0420","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1089\/jop.1994.10.319","article-title":"Platelet-activating factor antagonists and ocular inflammation","volume":"10","author":"Bazan","year":"1994","journal-title":"J. Ocul. Pharmacol."},{"issue":"5","key":"10.1016\/j.prostaglandins.2020.106522_bib0425","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1076\/ceyr.23.5.326.5445","article-title":"Platelet-activating factor (PAF) enhances apoptosis induced by ultraviolet radiation in corneal epithelial cells through cytochrome c-caspase activation","volume":"23","author":"Ma","year":"2001","journal-title":"Curr. Eye Res."},{"issue":"5","key":"10.1016\/j.prostaglandins.2020.106522_bib0430","doi-asserted-by":"crossref","first-page":"341","DOI":"10.3109\/02713689508999931","article-title":"Release of platelet activating factor (PAF) and eicosanoids in UVC-irradiated corneal stromal cells","volume":"14","author":"Sheng","year":"1995","journal-title":"Curr. Eye Res."},{"issue":"3","key":"10.1016\/j.prostaglandins.2020.106522_bib0435","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1167\/iovs.05-0581","article-title":"Synergistic effect of platelet-activating factor and tumor necrosis factor-alpha on corneal myofibroblast apoptosis","volume":"47","author":"He","year":"2006","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"issue":"4","key":"10.1016\/j.prostaglandins.2020.106522_bib0440","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1016\/j.jcrs.2003.09.069","article-title":"Prevention of experimental diffuse lamellar keratitis using a novel platelet-activating factor receptor antagonist","volume":"30","author":"Esquenazi","year":"2004","journal-title":"J. Cataract Refract. Surg."},{"issue":"1","key":"10.1016\/j.prostaglandins.2020.106522_bib0445","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1001\/archopht.124.1.70","article-title":"Alkali-induced corneal stromal melting prevention by a novel platelet-activating factor receptor antagonist","volume":"124","author":"He","year":"2006","journal-title":"Arch. Ophthalmol."},{"issue":"1","key":"10.1016\/j.prostaglandins.2020.106522_bib0450","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1089\/jop.2009.0102","article-title":"Platelet-activating factor-induced intracellular signaling and release of cytokines and prostaglandin E2 in immortalized human corneal epithelial cells","volume":"26","author":"Sharif","year":"2010","journal-title":"J. Ocul. Pharmacol. Ther."},{"issue":"3","key":"10.1016\/j.prostaglandins.2020.106522_bib0455","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1016\/0006-291X(87)90495-5","article-title":"The accumulation of platelet activating factor in the injured cornea may be interrelated with the synthesis of lipoxygenase products","volume":"149","author":"Bazan","year":"1987","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"2","key":"10.1016\/j.prostaglandins.2020.106522_bib0460","first-page":"87","article-title":"Production of lipid mediators in experimental keratitis of rabbit eye","volume":"8","author":"Tjebbes","year":"1993","journal-title":"J. Lipid Mediat."},{"issue":"12","key":"10.1016\/j.prostaglandins.2020.106522_bib0465","first-page":"2492","article-title":"Platelet-activating factor induces cyclooxygenase-2 gene expression in corneal epithelium. Requirement of calcium in the signal transduction pathway","volume":"38","author":"Bazan","year":"1997","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"issue":"3","key":"10.1016\/j.prostaglandins.2020.106522_bib0470","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1089\/jop.1995.11.329","article-title":"Activation of the phospholipase\/cyclooxygenase cascade in the rabbit cornea by platelet-activating factor is challenged by PAF receptor antagonists","volume":"11","author":"Hurst","year":"1995","journal-title":"J. Ocul. Pharmacol. Ther."},{"issue":"4","key":"10.1016\/j.prostaglandins.2020.106522_bib0475","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/j.exer.2004.12.023","article-title":"Cellular and molecular events in corneal wound healing: significance of lipid signalling","volume":"80","author":"Bazan","year":"2005","journal-title":"Exp. Eye Res."},{"issue":"9","key":"10.1016\/j.prostaglandins.2020.106522_bib0480","doi-asserted-by":"crossref","first-page":"2915","DOI":"10.1167\/iovs.04-0128","article-title":"Platelet-activating factor (PAF) induces corneal neovascularization and upregulates VEGF expression in endothelial cells","volume":"45","author":"Ma","year":"2004","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"issue":"12","key":"10.1016\/j.prostaglandins.2020.106522_bib0485","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.3109\/02713683.2010.513797","article-title":"The induction of an angiogenic response in corneal myofibroblasts by platelet-activating factor (PAF)","volume":"35","author":"He","year":"2010","journal-title":"Curr. Eye Res."},{"issue":"1","key":"10.1016\/j.prostaglandins.2020.106522_bib0490","doi-asserted-by":"crossref","first-page":"53","DOI":"10.3109\/15569527.2014.903573","article-title":"Inhibitory effects of the platelet-activating factor receptor antagonists, CV-3988 and Ginkgolide B, on alkali burn-induced corneal neovascularization","volume":"34","author":"Lee","year":"2015","journal-title":"Cutan. Ocul. Toxicol."},{"issue":"2","key":"10.1016\/j.prostaglandins.2020.106522_bib0495","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.avsg.2007.11.002","article-title":"Vascular endothelial growth factor induces extracellular matrix proteins and osteopontin in the umbilical artery","volume":"22","author":"Infanger","year":"2008","journal-title":"Ann. Vasc. Surg."},{"key":"10.1016\/j.prostaglandins.2020.106522_bib0500","doi-asserted-by":"crossref","first-page":"38342","DOI":"10.1038\/srep38342","article-title":"Analysis of the Serum Lipid Profile in Polypoidal Choroidal Vasculopathy","volume":"6","author":"Li","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.prostaglandins.2020.106522_bib0505","article-title":"NFAT5 promotes arteriogenesis via MCP-1-dependent monocyte recruitment","author":"Lin","year":"2019","journal-title":"J. Cell. Mol. Med."},{"issue":"2","key":"10.1016\/j.prostaglandins.2020.106522_bib0510","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1006\/jsre.1996.0146","article-title":"Hypoxia\/reoxygenation of human endothelium activates PMNs to detach endothelial cells via a PAF mechanism","volume":"61","author":"Franciose","year":"1996","journal-title":"J. Surg. Res."},{"issue":"5","key":"10.1016\/j.prostaglandins.2020.106522_bib0515","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1076\/ceyr.18.5.342.5346","article-title":"Intravitreally injected platelet activating factor induces retinitis in experimental animals","volume":"18","author":"Rosenbaum","year":"1999","journal-title":"Curr. Eye Res."},{"issue":"4","key":"10.1016\/j.prostaglandins.2020.106522_bib0520","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1096\/fj.10-160051","article-title":"Noninvasive molecular imaging reveals role of PAF in leukocyte-endothelial interaction in LPS-induced ocular vascular injury","volume":"25","author":"Garland","year":"2011","journal-title":"FASEB J."},{"issue":"1","key":"10.1016\/j.prostaglandins.2020.106522_bib0525","first-page":"432","article-title":"PAF receptor antagonist Ginkgolide B inhibits tumourigenesis and angiogenesis in colitis-associated cancer","volume":"8","author":"Sun","year":"2015","journal-title":"Int. J. Clin. Exp. Pathol."},{"issue":"1","key":"10.1016\/j.prostaglandins.2020.106522_bib0530","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/s12348-018-0155-6","article-title":"An update on inflammatory choroidal neovascularization: epidemiology, multimodal imaging, and management","volume":"8","author":"Agarwal","year":"2018","journal-title":"J. Ophthalmic Inflamm. Infect."},{"issue":"12","key":"10.1016\/j.prostaglandins.2020.106522_bib0535","doi-asserted-by":"crossref","first-page":"6492","DOI":"10.4049\/jimmunol.154.12.6492","article-title":"Platelet-activating factor directly stimulates in vitro migration of endothelial cells and promotes in vivo angiogenesis by a heparin-dependent mechanism","volume":"154","author":"Camussi","year":"1995","journal-title":"J. Immunol."},{"issue":"11","key":"10.1016\/j.prostaglandins.2020.106522_bib0540","doi-asserted-by":"crossref","first-page":"2369","DOI":"10.1016\/j.febslet.2005.03.035","article-title":"Involvement of matrix metalloproteinase-9 in platelet-activating factor-induced angiogenesis","volume":"579","author":"Ko","year":"2005","journal-title":"FEBS Lett."},{"issue":"3","key":"10.1016\/j.prostaglandins.2020.106522_bib0545","first-page":"697","article-title":"Effects of platelet-activating factor on the release of arachidonic acid and prostaglandins by rabbit iris smooth muscle","volume":"228","author":"Yousufzai","year":"1985","journal-title":"Inhibition by calcium channel antagonists, Biochem J"},{"issue":"11","key":"10.1016\/j.prostaglandins.2020.106522_bib0550","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.3109\/02713688809001876","article-title":"Specific receptor sites for PAF in iris and ciliary body of the rabbit eye","volume":"7","author":"van Delft","year":"1988","journal-title":"Curr. Eye Res."},{"issue":"1","key":"10.1016\/j.prostaglandins.2020.106522_bib0555","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/0006-291X(89)91648-3","article-title":"Characterization of specific binding sites for PAF in the iris and ciliary body of rabbit","volume":"160","author":"Domingo","year":"1989","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.prostaglandins.2020.106522_bib0560","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/bs.ctdb.2018.12.008","article-title":"Eye organogenesis: a hierarchical view of ocular development","volume":"132","author":"Miesfeld","year":"2019","journal-title":"Curr. Top. Dev. Biol."},{"key":"10.1016\/j.prostaglandins.2020.106522_bib0565","doi-asserted-by":"crossref","DOI":"10.1002\/JLB.3MIR0817-337R","article-title":"Negative regulators that mediate ocular immune privilege","author":"Taylor","year":"2018","journal-title":"J. Leukoc. Biol."},{"issue":"3","key":"10.1016\/j.prostaglandins.2020.106522_bib0570","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1001\/archopht.1991.01080030112049","article-title":"Synthesis of platelet activating factor by ocular tissue from inflamed eyes","volume":"109","author":"Rosenbaum","year":"1991","journal-title":"Arch. Ophthalmol."},{"issue":"11","key":"10.1016\/j.prostaglandins.2020.106522_bib0575","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.3109\/02713689209015078","article-title":"Intracamerally injected platelet activating factor (PAF) induces marked intraocular inflammatory reactions","volume":"11","author":"Sheng","year":"1992","journal-title":"Curr. Eye Res."},{"issue":"2","key":"10.1016\/j.prostaglandins.2020.106522_bib0580","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/1043-6618(92)91388-W","article-title":"Effects of prostaglandins and PAF on the contractility of the bovine ciliary muscle","volume":"25","author":"Lograno","year":"1992","journal-title":"Pharmacol. Res."},{"issue":"9","key":"10.1016\/j.prostaglandins.2020.106522_bib0585","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/0024-3205(89)90170-7","article-title":"Calcium-mobilizing receptors, polyphosphoinositides, generation of second messengers and contraction in the mammalian iris smooth muscle: historical perspectives and current status","volume":"45","author":"Abdel-Latif","year":"1989","journal-title":"Life Sci."},{"issue":"6","key":"10.1016\/j.prostaglandins.2020.106522_bib0590","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1016\/0898-6568(92)90058-G","article-title":"Activation of phospholipase D by endothelin-1 and other pharmacological agents in rabbit iris sphincter smooth muscle","volume":"4","author":"Zhang","year":"1992","journal-title":"Cell. Signal."},{"issue":"6","key":"10.1016\/j.prostaglandins.2020.106522_bib0595","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1111\/j.1444-0938.2010.00532.x","article-title":"Accommodating intraocular lenses: a review of design concepts, usage and assessment methods","volume":"93","author":"Sheppard","year":"2010","journal-title":"Clin. Exp. Optom."},{"issue":"6","key":"10.1016\/j.prostaglandins.2020.106522_bib0600","first-page":"1101","article-title":"Platelet-activating factor and laser trauma of the iris","volume":"30","author":"Verbey","year":"1989","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"issue":"5","key":"10.1016\/j.prostaglandins.2020.106522_bib0605","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/S0014-4835(05)80047-8","article-title":"Immortalization of cat iris sphincter smooth muscle cells by SV40 virus: growth, morphological, biochemical and pharmacological characteristics","volume":"61","author":"Ocklind","year":"1995","journal-title":"Exp. Eye Res."},{"issue":"6","key":"10.1016\/j.prostaglandins.2020.106522_bib0610","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1111\/j.1471-4159.1988.tb01155.x","article-title":"Acetylcholine and dopamine promote the production of platelet activating factor in immature cells of chick embryonic retina","volume":"51","author":"Bussolino","year":"1988","journal-title":"J. Neurochem."},{"key":"10.1016\/j.prostaglandins.2020.106522_bib0615","doi-asserted-by":"crossref","first-page":"41959","DOI":"10.1038\/srep41959","article-title":"Platelet activating factor-induced expression of p21 is correlated with histone acetylation","volume":"7","author":"Damiani","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.prostaglandins.2020.106522_bib0620","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/1477-5956-6-34","article-title":"Protein expression profiling during chick retinal maturation: a proteomics-based approach","volume":"6","author":"Finnegan","year":"2008","journal-title":"Proteome Sci."},{"issue":"1","key":"10.1016\/j.prostaglandins.2020.106522_bib0625","doi-asserted-by":"crossref","first-page":"8269","DOI":"10.1038\/s41598-017-08809-x","article-title":"PAFAH1B1 haploinsufficiency disrupts GABA neurons and synaptic E\/I balance in the dentate gyrus","volume":"7","author":"Dinday","year":"2017","journal-title":"Sci. Rep."},{"issue":"35","key":"10.1016\/j.prostaglandins.2020.106522_bib0630","doi-asserted-by":"crossref","first-page":"16502","DOI":"10.1016\/S0021-9258(18)66594-9","article-title":"Production of platelet-activating factor by chick retina","volume":"261","author":"Bussolino","year":"1986","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.prostaglandins.2020.106522_bib0635","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/0014-2999(89)90400-7","article-title":"Presence of specific platelet-activating factor binding sites in the rat retina","volume":"163","author":"Thierry","year":"1989","journal-title":"Eur. J. Pharmacol."},{"issue":"12","key":"10.1016\/j.prostaglandins.2020.106522_bib0640","doi-asserted-by":"crossref","first-page":"6688","DOI":"10.1167\/iovs.09-4835","article-title":"Alpha2-adrenergic receptors and their core involvement in the process of axonal growth in retinal explants","volume":"51","author":"Prokosch","year":"2010","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"issue":"Suppl 2","key":"10.1016\/j.prostaglandins.2020.106522_bib0645","doi-asserted-by":"crossref","first-page":"S23","DOI":"10.1016\/S0039-6257(97)80004-5","article-title":"Signal transduction and gene expression in the eye: a contemporary view of the pro-inflammatory, anti-inflammatory and modulatory roles of prostaglandins and other bioactive lipids","volume":"41","author":"Bazan","year":"1997","journal-title":"Surv. Ophthalmol."},{"issue":"5","key":"10.1016\/j.prostaglandins.2020.106522_bib0650","first-page":"283","article-title":"Platelet-activating factor production occurs through stimulation of cholinergic and dopaminergic receptors in the chick retina","volume":"1","author":"Bussolino","year":"1989","journal-title":"J. Lipid Mediat."},{"issue":"Suppl","key":"10.1016\/j.prostaglandins.2020.106522_bib0655","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/0031-6989(86)90053-6","article-title":"Comparative effects of leukotrienes and PAF-acether electrophysiological activity of the rat retina","volume":"18","author":"Doly","year":"1986","journal-title":"Pharmacol. Res. Commun."},{"issue":"1","key":"10.1016\/j.prostaglandins.2020.106522_bib0660","first-page":"33","article-title":"Effects of PAF-acether on electrophysiological response of isolated retina","volume":"9","author":"Doly","year":"1987","journal-title":"Int. J. Tissue React."},{"issue":"5","key":"10.1016\/j.prostaglandins.2020.106522_bib0665","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1159\/000267331","article-title":"Prevention of chloroquine-induced electroretinographic damage by a new platelet-activating factor antagonist, BN 50730","volume":"25","author":"Doly","year":"1993","journal-title":"Ophthalmic Res."},{"issue":"3","key":"10.1016\/j.prostaglandins.2020.106522_bib0670","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/0162-3109(87)90057-9","article-title":"Effects of platelet-activating factor on electrophysiology of isolated retinas and their inhibition by BN 52021, a specific PAF-acether receptor antagonist","volume":"13","author":"Doly","year":"1987","journal-title":"Immunopharmacology"},{"issue":"4","key":"10.1016\/j.prostaglandins.2020.106522_bib0675","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.preteyeres.2006.05.003","article-title":"M\u00fcller cells in the healthy and diseased retina","volume":"25","author":"Bringmann","year":"2006","journal-title":"Prog. Retin. Eye Res."},{"issue":"4860","key":"10.1016\/j.prostaglandins.2020.106522_bib0680","doi-asserted-by":"crossref","first-page":"1792","DOI":"10.1126\/science.3381103","article-title":"Neuroregulatory and neuropathological actions of the ether-phospholipid platelet-activating factor","volume":"240","author":"Kornecki","year":"1988","journal-title":"Science"},{"issue":"5","key":"10.1016\/j.prostaglandins.2020.106522_bib0685","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.plefa.2005.02.004","article-title":"New insights into the retinal circulation: inflammatory lipid mediators in ischemic retinopathy","volume":"72","author":"Hardy","year":"2005","journal-title":"Prostaglandins Leukot. Essent. Fatty Acids"},{"issue":"9","key":"10.1016\/j.prostaglandins.2020.106522_bib0690","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1183\/09031936.93.03091002","article-title":"Generation of oxygen free radicals from blood eosinophils from asthma patients after stimulation with PAF or phorbol ester","volume":"3","author":"Chanez","year":"1990","journal-title":"Eur. Respir. J."},{"issue":"2","key":"10.1016\/j.prostaglandins.2020.106522_bib0695","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1016\/S0022-3565(25)38761-6","article-title":"Role of platelet-activating factor (PAF) in oxygen radical-induced cardiac dysfunction","volume":"269","author":"Alloatti","year":"1994","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"10","key":"10.1016\/j.prostaglandins.2020.106522_bib0700","first-page":"3327","article-title":"Platelet-activating factor in vasoobliteration of oxygen-induced retinopathy","volume":"43","author":"Beauchamp","year":"2002","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"issue":"3","key":"10.1016\/j.prostaglandins.2020.106522_bib0705","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21030704","article-title":"Mechanisms and treatment of light-induced retinal degeneration-associated inflammation: insights from biochemical profiling of the aqueous humor","volume":"21","author":"Chistyakov","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"6","key":"10.1016\/j.prostaglandins.2020.106522_bib0710","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1016\/j.exer.2005.04.017","article-title":"Oxidative stress-induced retinal damage up-regulates DNA polymerase gamma and 8-oxoguanine-DNA-glycosylase in photoreceptor synaptic mitochondria","volume":"81","author":"Cortina","year":"2005","journal-title":"Exp. Eye Res."},{"issue":"6","key":"10.1016\/j.prostaglandins.2020.106522_bib0715","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1007\/BF00181782","article-title":"Light and lithium effects in the rat retina: modification by the PAF antagonist BN 52021","volume":"230","author":"Rem\u00e9","year":"1992","journal-title":"Graefes Arch. Clin. Exp. Ophthalmol."},{"issue":"11","key":"10.1016\/j.prostaglandins.2020.106522_bib0720","doi-asserted-by":"crossref","first-page":"957","DOI":"10.3109\/02713680903231135","article-title":"Functional analysis of platelet-activating factor in the retinal pigment epithelial cells and choroidal endothelial cells","volume":"34","author":"He","year":"2009","journal-title":"Curr. Eye Res."},{"issue":"11","key":"10.1016\/j.prostaglandins.2020.106522_bib0725","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.3109\/02713689109020341","article-title":"Production of platelet-activating factor in photocoagulated retinas","volume":"10","author":"Dharma","year":"1991","journal-title":"Curr. Eye Res."},{"issue":"4","key":"10.1016\/j.prostaglandins.2020.106522_bib0730","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1006\/exer.1994.1127","article-title":"Role of neutrophils in breakdown of the blood-retinal barrier following intravitreal injection of platelet-activating factor","volume":"59","author":"Smith","year":"1994","journal-title":"Exp. Eye Res."},{"issue":"1\u20132","key":"10.1016\/j.prostaglandins.2020.106522_bib0735","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.jneuroim.2006.09.015","article-title":"TNF-alpha is critical for ischemia-induced leukostasis, but not retinal neovascularization nor VEGF-induced leakage","volume":"182","author":"Vinores","year":"2007","journal-title":"J. Neuroimmunol."},{"issue":"2","key":"10.1016\/j.prostaglandins.2020.106522_bib0740","doi-asserted-by":"crossref","first-page":"449","DOI":"10.3892\/ijmm.2013.1588","article-title":"The 15-deoxy-\u03b412,14-prostaglandin J2 inhibits LPS\u2011stimulated inflammation via enhancement of the platelet\u2011activating factor acetylhydrolase activity in human retinal pigment epithelial cells","volume":"33","author":"Jung","year":"2014","journal-title":"Int. J. Mol. Med."},{"issue":"4","key":"10.1016\/j.prostaglandins.2020.106522_bib0745","doi-asserted-by":"crossref","first-page":"231","DOI":"10.3109\/09273949409057081","article-title":"Ginkgo biloba extract (EGb 761) and a platelet-activating factor antagonist protect the retina in experimental autoimmune uveoretinitis","volume":"2","author":"De Kozak","year":"1994","journal-title":"Ocul. Immunol. Inflamm."},{"issue":"4","key":"10.1016\/j.prostaglandins.2020.106522_bib0750","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1089\/108076803322279372","article-title":"The role of platelet activating factor and the efficacy of apafant ophthalmic solution in experimental allergic conjunctivitis","volume":"19","author":"Kato","year":"2003","journal-title":"J. Ocul. Pharmacol. Ther."},{"key":"10.1016\/j.prostaglandins.2020.106522_bib0755","doi-asserted-by":"crossref","first-page":"138513","DOI":"10.1155\/2009\/138513","article-title":"A novel platelet activating factor receptor antagonist reduces cell infiltration and expression of inflammatory mediators in mice exposed to desiccating conditions after PRK","volume":"2009","author":"Esquenazi","year":"2009","journal-title":"Clin. Dev. Immunol."},{"issue":"1","key":"10.1016\/j.prostaglandins.2020.106522_bib0760","doi-asserted-by":"crossref","first-page":"19","DOI":"10.3109\/02713689109007607","article-title":"Prolonged effect of a new platelet-activating factor antagonist on ocular vascular permeability in an endotoxin model of uveitis","volume":"10","author":"Lin","year":"1991","journal-title":"Curr. Eye Res."},{"key":"10.1016\/j.prostaglandins.2020.106522_bib0765","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1186\/s12886-015-0030-2","article-title":"Protective effect of high concentration of BN52021 on retinal contusion in cat eyes","volume":"15","author":"Huang","year":"2015","journal-title":"BMC Ophthalmol."},{"issue":"10","key":"10.1016\/j.prostaglandins.2020.106522_bib0770","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1080\/14740338.2016.1221399","article-title":"Rupatadine: global safety evaluation in allergic rhinitis and urticaria","volume":"15","author":"Gonz\u00e1lez-N\u00fa\u00f1ez","year":"2016","journal-title":"Expert Opin. Drug Saf."},{"issue":"2","key":"10.1016\/j.prostaglandins.2020.106522_bib0775","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.alit.2018.08.011","article-title":"Efficacy and safety of rupatadine in Japanese patients with seasonal allergic rhinitis: a double-blind, randomized, multicenter, placebo-controlled clinical trial","volume":"68","author":"Okubo","year":"2019","journal-title":"Allergol. Int."},{"issue":"11","key":"10.1016\/j.prostaglandins.2020.106522_bib0780","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1185\/03007995.2013.822855","article-title":"Efficacy and safety of rupatadine for allergic rhino-conjunctivitis: a systematic review of randomized, double-blind, placebo-controlled studies with meta-analysis","volume":"29","author":"Compalati","year":"2013","journal-title":"Curr. Med. Res. Opin."},{"issue":"1","key":"10.1016\/j.prostaglandins.2020.106522_bib0785","doi-asserted-by":"crossref","first-page":"e296","DOI":"10.1038\/oncsis.2016.90","article-title":"Platelet-activating factor (PAF) receptor as a promising target for cancer cell repopulation after radiotherapy","volume":"6","author":"da Silva","year":"2017","journal-title":"Oncogenesis"},{"key":"10.1016\/j.prostaglandins.2020.106522_bib0790","doi-asserted-by":"crossref","first-page":"10","DOI":"10.3389\/fonc.2018.00010","article-title":"Platelet-activating factor receptor ligands protect tumor cells from radiation-induced cell death","volume":"8","author":"da Silva-Junior","year":"2018","journal-title":"Front. Oncol."},{"issue":"1","key":"10.1016\/j.prostaglandins.2020.106522_bib0795","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1093\/advances\/nmy090","article-title":"The potential role of dietary platelet-activating factor inhibitors in Cancer prevention and treatment","volume":"10","author":"Lordan","year":"2019","journal-title":"Adv. Nutr."},{"issue":"2","key":"10.1016\/j.prostaglandins.2020.106522_bib0800","doi-asserted-by":"crossref","first-page":"H811","DOI":"10.1152\/ajpheart.00235.2002","article-title":"Omega-3 fatty acids suppress monocyte adhesion to human endothelial cells: role of endothelial PAF generation","volume":"283","author":"Mayer","year":"2002","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"issue":"1","key":"10.1016\/j.prostaglandins.2020.106522_bib0805","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1007\/s40135-014-0059-z","article-title":"Nutritional supplements for age-related macular degeneration","volume":"3","author":"Gregori","year":"2015","journal-title":"Curr. Ophthalmol. Rep."},{"key":"10.1016\/j.prostaglandins.2020.106522_bib0810","doi-asserted-by":"crossref","DOI":"10.1007\/s00018-019-03419-4","article-title":"The role of lymphocytes and phagocytes in age-related macular degeneration (AMD)","author":"Behnke","year":"2020","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.prostaglandins.2020.106522_bib0815","article-title":"Pericytes, inflammation, and diabetic retinopathy","author":"Spencer","year":"2019","journal-title":"Inflammopharmacology"},{"issue":"1","key":"10.1016\/j.prostaglandins.2020.106522_bib0820","doi-asserted-by":"crossref","DOI":"10.3390\/jcm9010216","article-title":"Do Genomic Factors Play a Role in Diabetic Retinopathy?","volume":"9","author":"Cabrera","year":"2020","journal-title":"J. Clin. Med."},{"issue":"15","key":"10.1016\/j.prostaglandins.2020.106522_bib0825","doi-asserted-by":"crossref","first-page":"2636","DOI":"10.1002\/pmic.200600486","article-title":"Proteome map of normal rat retina and comparison with the proteome of diabetic rat retina: new insight in the pathogenesis of diabetic retinopathy","volume":"7","author":"Quin","year":"2007","journal-title":"Proteomics"},{"issue":"1","key":"10.1016\/j.prostaglandins.2020.106522_bib0830","doi-asserted-by":"crossref","first-page":"43","DOI":"10.2337\/diabetes.48.1.43","article-title":"Recombinant human platelet-activating factor acetylhydrolase reduces the frequency of diabetes in the diabetes-prone BB rat","volume":"48","author":"Lee","year":"1999","journal-title":"Diabetes"},{"issue":"3","key":"10.1016\/j.prostaglandins.2020.106522_bib0835","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1111\/jphp.12683","article-title":"Chinese herbal drugs for the treatment of diabetic retinopathy","volume":"69","author":"Behl","year":"2017","journal-title":"J. Pharm. Pharmacol."},{"issue":"4","key":"10.1016\/j.prostaglandins.2020.106522_bib0840","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/j.survophthal.2017.12.008","article-title":"Angiogenesis and lymphangiogenesis in corneal transplantation-A review","volume":"63","author":"Zhong","year":"2018","journal-title":"Surv. Ophthalmol."},{"issue":"3","key":"10.1016\/j.prostaglandins.2020.106522_bib0845","first-page":"151","article-title":"[Corneal epithelial wound healing is delayed by platelet activating factor treatment]","volume":"40","author":"Ma","year":"2004","journal-title":"Zhonghua Yan Ke Za Zhi"},{"issue":"2","key":"10.1016\/j.prostaglandins.2020.106522_bib0850","doi-asserted-by":"crossref","first-page":"139","DOI":"10.3109\/02713689409042408","article-title":"A platelet-activating factor antagonist reduces corneal allograft inflammation and neovascularization","volume":"13","author":"Cohen","year":"1994","journal-title":"Curr. Eye Res."},{"issue":"6","key":"10.1016\/j.prostaglandins.2020.106522_bib0855","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1016\/j.healun.2003.07.010","article-title":"Captopril suppresses post-transplantation angiogenic activity in rat allograft coronary vessels","volume":"23","author":"Crawford","year":"2004","journal-title":"J. Heart Lung Transplant."},{"issue":"6","key":"10.1016\/j.prostaglandins.2020.106522_bib0860","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1038\/eye.2016.298","article-title":"Hydroxychloroquine retinopathy","volume":"31","author":"Yusuf","year":"2017","journal-title":"Eye Lond. (Lond)"},{"issue":"8","key":"10.1016\/j.prostaglandins.2020.106522_bib0865","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.4161\/auto.29428","article-title":"Outcome of early clinical trials of the combination of hydroxychloroquine with chemotherapy in cancer","volume":"10","author":"Poklepovic","year":"2014","journal-title":"Autophagy"},{"issue":"3","key":"10.1016\/j.prostaglandins.2020.106522_bib0870","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1038\/s41422-020-0282-0","article-title":"Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro","volume":"30","author":"Wang","year":"2020","journal-title":"Cell Res."},{"issue":"5","key":"10.1016\/j.prostaglandins.2020.106522_bib0875","doi-asserted-by":"crossref","first-page":"3415","DOI":"10.1167\/iovs.14-16345","article-title":"Localization of damage in progressive hydroxychloroquine retinopathy on and off the drug: inner versus outer retina, parafovea versus peripheral fovea","volume":"56","author":"de Sisternes","year":"2015","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.prostaglandins.2020.106522_bib0880","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.tox.2013.03.012","article-title":"Chloroquine causes similar electroretinogram modifications, neuronal phospholipidosis and marked impairment of synaptic vesicle transport in albino and pigmented rats","volume":"308","author":"Lezmi","year":"2013","journal-title":"Toxicology"},{"issue":"4","key":"10.1016\/j.prostaglandins.2020.106522_bib0885","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/S0049-3848(02)00036-1","article-title":"Cationic amphiphilic drugs and platelet phospholipase A(2) (cPLA(2))","volume":"105","author":"Nos\u00e1l","year":"2002","journal-title":"Thromb. Res."},{"issue":"3\u20134","key":"10.1016\/j.prostaglandins.2020.106522_bib0890","first-page":"521","article-title":"Effect of Gingko biloba extract (EGb 761) on chloroquine induced retinal alterations","volume":"9","author":"Droy-Lefaix","year":"1992","journal-title":"Lens Eye Toxic. Res."}],"container-title":["Prostaglandins &amp; Other Lipid Mediators"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1098882320301155?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1098882320301155?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T02:01:55Z","timestamp":1761098515000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1098882320301155"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4]]},"references-count":178,"alternative-id":["S1098882320301155"],"URL":"https:\/\/doi.org\/10.1016\/j.prostaglandins.2020.106522","relation":{},"ISSN":["1098-8823"],"issn-type":[{"value":"1098-8823","type":"print"}],"subject":[],"published":{"date-parts":[[2021,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Platelet activating factor in the eye: Physiological roles, diseases and future perspectives","name":"articletitle","label":"Article Title"},{"value":"Prostaglandins & Other Lipid Mediators","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.prostaglandins.2020.106522","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"106522"}}